aucubin has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, X; Du, W; Jin, X; Li, J; Lu, X; Ma, B; Ren, C; Wang, X; Wei, J; Zhang, Q | 1 |
| Ai, Q; Dong, Y; Jiang, W; Ma, H; Shi, X; Shi, Y; Wang, Z; Yang, X; Zhang, Y | 1 |
2 other study(ies) available for aucubin and Cirrhosis, Liver
| Article | Year |
|---|---|
Aucubin ameliorates liver fibrosis and hepatic stellate cells activation in diabetic mice via inhibiting ER stress-mediated IRE1α/TXNIP/NLRP3 inflammasome through NOX4/ROS pathway.
Topics: Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endoribonucleases; Fibrosis; Hepatic Stellate Cells; Inflammasomes; Iridoid Glucosides; Liver Cirrhosis; Mice; Molecular Docking Simulation; NADPH Oxidase 4; Nitrosamines; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidoreductases; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Thioredoxins; Transforming Growth Factor beta1 | 2022 |
Aucubin inhibits hepatic stellate cell activation through stimulating Nrf2/Smad7 axis.
Topics: Animals; Collagen Type I; Disease Models, Animal; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Mice; NF-E2-Related Factor 2; Transforming Growth Factor beta | 2023 |